A carregar...
ANGI-15. NANOFORMULATION OF A VASCULAR DISRUPTING AGENT FOR THE TREATMENT OF GLIOMA WITH MRI MONITORING
Anti-angiogenesis therapy VEGF-VEGF receptors axis alone or in combination with other therapeutic agents have demonstrated mixed results, with the majority of reports indicating that glioblastoma (GBM) developed resistance against anti-angiogenesis therapy as well as small molecular receptor tyrosin...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5691887/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.093 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|